Faculty in Cancer Biology


J Lucas Argueso
Assistant Professor (Environmental & Radiology Health Sciences); Ph.D. Cornell 2004. Molecular mechanisms involved in the formation of gene Copy Number Variation (CNV) and other chromosomal rearrangements. Genomics of industrial yeast strains used in biofuels production.

Susan M. Bailey

Susan M. Bailey

Associate Professor (Environmental & Radiology Health Sciences); Ph.D. New Mexico 2000. Potential role of dysfunctional (uncapped) telomeres in tumorigenesis studied with fluorescence in situ hybridization (FISH).

James Bamburg

James R. Bamburg
Professor (Biochemistry and Molecular Biology); Ph.D. Wisconsin 1969. Regulation of the cytoskeleton in neuronal growth and pathfinding; signal transduction pathways regulating actin dynamics; abnormalities in actin behavior in neurodegenative diseases.

Barbara Biller

Barbara J. Biller
Assistant Professor (Clinical Sciences); Ph.D. Colorado State University 2007. Chemotherapy and antitumor immunity; preclinical and clinical cancer immunotherapeutics.

Mark Brown

Mark Brown
Associate Professor (Clinical Sciences); Ph.D. University of Texas 2007. Molecular oncology and small molecule drug development.


Robert Cohen
Professor (Biochemistry & Molecular Biology); Ph.D. University of California, Berkeley 1980. Regulation of ubiquitin-dependent signaling, protein degradation by the 26S proteasome, and deubiquitination.


Jennifer G. DeLuca
Associate Professor (Biochemistry & Molecular Biology); Ph.D. University of California at Santa Barbara 2000. Mechanisms of Mitotic Chromosome Segregation.

Stephen Dow

Steven W. Dow
Professor (Microbiology, Immunology & Pathology and Clinical Sciences); Ph.D. Colorado State University, 1992. Innate immunity and the lung; bacterial pathogenesis; cancer immunology; vaccines.

Dawn Duval

Dawn L. Duval
Assistant Professor (Clinical Sciences); Ph.D. University of Nevada 1994. Molecular mechanisms of carcinogenesis and metastasis in osteosarcoma and breast cancer models.

Nicole Ehrhart

Nicole Ehrhart
Professor (Clinical Sciences); V.M.D. University of Pennsylvania 1990. Limb preservation; musculoskeletal sarcoma; orthopaedic oncology; bone regeneration, and tissue engineering.

Dan Gustafson

Daniel L. Gustafson
Associate Professor (Clinical Sciences); Ph.D., University of Nevada, Reno, 1992. Cancer pharmacology, pharmacokinetics and toxicology.


Charles S. Henry
Professor (Chemistry); Ph.D., Arkansas, 1998. Bioanalytical chemistry; chemical separations and chemical nature of disease.


Takanitsu Kato
Assistant Professor (Environmental & Radiological Health Sciences); Ph.D., Colorado State University. Investigating DNA repair after high LET radiation exposure.


Susan Kraft
Professor (Environmental & Radiological Health Sciences); Ph.D., Washington State University, 1991. Cancer imaging, Magnetic Resonance Imaging and spectroscopy, radiation therapy and neuroradiology.


Susan M. LaRue
Professor (Environmental & Radiological Health Sciences); D.V.M., Georgia; Ph.D., ColoradoState 1992. Experimental therapeutics; hyperthermia; tumor physiology; tumor cytogenetics.

Paul Laybourn

Paul J. Laybourn
Professor (Biochemistry and Molecular Biology); Ph.D. California (Davis) 1989. The mechanism of transcription regulation in a chromatin context.


Jac A. Nickoloff
Dept. Head & Professor (Environmental & Radiological Health Sciences); PhD. University of Colorado. Cellular processes that maintain eukaryotic genome stability, including homologous recombination, nonhomologous end-joining and other DNA repair processes.

Jennifer Nyborg

Jennifer K. Nyborg
Professor (Biochemistry & Molecular Biology); Ph.D. California (Riverside) 1986. The mechanism of transcriptional deregulation by the human T-cell leukemia virus (HTLV-I) tax protein.


Rodney L Page
Professor (Clinical Sciences) Ph.D. Colorado State University, 1981. Director of the Flint Animal Cancer Center.


Ashok Prasad
Assistant Professor (Chemical and Biological Engineering and School of Biomedical Engineering); Ph.D. Brandeis University, 2006. Mathematical and computational modeling of signal transduction and gene transcription, stochastic processes in biology, properties and dynamics of the cytoskeleton of mammalian cells, cancer drug sensitivity and resistance, modeling for synthetic biology applications in plants and single cells, genome-scale metabolic modeling of e. coli, cyanobacteria and algae.

Sandra Quackenbush

Sandra L. Quackenbush
Associate Professor, Associate Department Head (Microbiology, Immunology & Pathology); Ph.D., Colorado State University. Viral pathogenesis, particularly viral-induced oncogenesis.


F. Andrew Ray
Associate Professor (Environmental & Radiological Health Sciences); PhD. University of New Mexico School of Medicine. How the SV40 virus causes cancer traits in normal human cells.


Dan Regan
Assistant Professor (Microbiology Immunology and Pathology, CVMBS).  The focus of Dr. Regan’s laboratory is to increase our understanding of the interplay between the immune system and (non-immune) tumor stroma, and how these   compartments of the tumor microenvironment promote metastasis as well as respond to and mediate extrinsic mechanisms of resistance to anti-cancer therapy. To investigate this area of cancer biology, his laboratory utilizes a combination of in vitro 3-dimensional tumor co-culture models and animal models, focusing on breast and bone cancer (osteosarcoma). Our long-term research goal is to fully elucidate the mechanisms by which tumors prime non-malignant host stromal cells of distant organs to promote their metastasis and chemo-resistance, in order to identify novel targets for host-directed stromal therapies which “poison the soil” for effective combination with conventional tumor cell targeted drugs.

Elizabeth Ryan

Elizabeth Ryan
Associate Professor (Clinical Sciences); Ph.D. University of Rochester, 2006.

Doug Thamm

Douglas H. Thamm
Associate Professor (Clinical Sciences); V.M.D. University of Pennsylvania 1995. Signal transduction and its inhibition in comparative cancer models.


Henry J. Thompson
Professor (Horticulture & Landscape Architecture and Head of the Cancer Prevention Laboratory); Ph.D. Rutgers 1975. Biochemical and molecular approaches to cancer prevention; preclinical models and clinical investigations.


Michael M. Weil
Professor (Environmental & Radiological Health Sciences); Ph.D. University of Texas, Austin 1987. Genetic susceptibility to radiation-induced cancers.

Carol Wilusz

Carol Wilusz
Associate Professor (Microbiology, Immunology & Pathology); Ph.D Imerial College, London. Post-transcriptional control of gene expression in myotonic dystrophy. Interactions between viruses and the cellular mRNA decay machinery.


Claudia Wiese, Ph.D.

Claudia Wiese
Assistant Professor (Environmental & Radiological Health Sciences); Christian-Albrechts University, Germany (1995). Studies in the Wiese lab have the following emphasis: (1) to gain detailed information on the molecular mechanisms of DNA DSB repair processes that maintain genome integrity, and (2) to establish the links between new factors in DSB repair and their roles in cancer avoidance. We are using biochemical, structural and cell biological methods, in combination with mouse genetics, to tackle different aspects of DSB repair and genome maintenance mechanisms from molecules to mice.



Stephen Withrow
Professor (Clinical Sciences); University of Minnesota (1972) Surgical residency at the Animal Medical Center in New York Cit. Surgical oncology, allografts, companion animal models of cancer for translational research, multimodality cancer treatment, local chemotherapy delivery systems, limb sparing and clinical trials.


Tingting Yao
Assistant Professor (Biochemistry & Molecular Biology); Ph.D. University of Iowa 2002. Regulation of gene expression and chromatin dynamics by the ubiquitin-proteasome pathway.

Updated 10/18/2017